Recombinant tissue plasminogen activator for hemodynamically stable patients experiencing an acute pulmonary embolism: A meta-analysis

Thrombosis Research

Volumn 134, Issue 1, 2014, Pages 50-56

  Liu, Yunfeng ^a   Lu, Youjin ^a   Song, Jian ^a   Li, Dan ^a   Liu, Hongyan ^a   Yang, Jin ^a   Zhao, Hui ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

embolism; hemodynamically stable; heparin; meta analysis; thrombolysis

Indexed keywords

ALTEPLASE; HEPARIN; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLEEDING; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; FIBRINOLYTIC THERAPY; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMICS; HUMAN; LUNG EMBOLISM; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; ACUTE DISEASE; FEMALE; MALE; PROCEDURES; PROGNOSIS; PULMONARY EMBOLISM;

ACUTE DISEASE; FEMALE; HEPARIN; HUMANS; MALE; PROGNOSIS; PULMONARY EMBOLISM; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84902547321     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.04.007     Document Type: Article

References (35)

1. A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galie, and P. Pruszczyk et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Eur Heart J 29 2008 2276 2315
2. M.R. Jaff, M.S. McMurtry, S.L. Archer, M. Cushman, N. Goldenberg, and S.Z. Goldhaber et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association Circulation 123 2011 1788 1830
3. B. Tardy, C. Venet, F. Zeni, M. Coudrot, S. Guyomarc'h, and P. Mismetti Short term effect of recombinant tissue plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: results of a meta-analysis involving 464 patients Thromb Res 124 2009 672 677
4. N. Kucher, E. Rossi, M. De Rosa, and S.Z. Goldhaber Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher Arch Intern Med 165 2005 1777
5. S. Konstantinides, A. Geibel, G. Heusel, F. Heinrich, W. Kasper, and S. Management et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism N Engl J Med 347 2002 1143 1150
6. C. Becattini, G. Agnelli, A. Salvi, S. Grifoni, L.G. Pancaldi, and I. Enea et al. Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism Thromb Res 125 2010 e82 e86
7. S. Fasullo, S. Scalzo, G. Maringhini, F. Ganci, S. Cannizzaro, and I. Basile et al. Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin Am J Med Sci 341 2011 33 39
8. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J.M. Reynolds, and D.J. Gavaghan et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
9. N.M. Laird, and F. Mosteller Some statistical methods for combining experimental results Int J Technol Assess Health Care 6 1990 5 30
10. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses Br Med J 327 2003 557
11. U. Tebbe, P. Bramlage, A. Graf, P. Lechleitner, C. Bode, and F.-C. Riess et al. Desmoteplase in acute massive pulmonary thromboembolism Thromb Haemost 101 2009 557 562
12. D. Mühl, R. Füredi, K. Gecse, S. Ghosh, B. Falusi, and L. Bogar et al. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism Blood Coagul Fibrinolysis 18 2007 661 667
13. U. Tebbe, A. Graf, W. Kamke, R. Zahn, F. Forycki, and G. Kratzsch et al. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism Am Heart J 138 1999 39 44
14. N. Meneveau, F. Schiele, D. Metz, B. Valette, P. Attali, and A. Vuillemenot et al. Comparative Efficacy of a Two-Hour Regimen of Streptokinase Versus Alteplase in Acute Massive Pulmonary Embolism: Immediate Clinical and Hemodynamic Outcome and One-Year Follow-Up 1 J Am Coll Cardiol 31 1998 1057 1063
15. N. Meneveau, F. Schiele, A. Vuillemenot, B. Valette, G. Grollier, and Y. Bernard et al. Streptokinase vs alteplase in massive pulmonary embolism A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction Eur Heart J 18 1997 1141 1148
16. H. Sors, G. Pacouret, R. Azarian, G. Meyer, B. Charbonnier, and G. Simonneau Hemodynamic Effects of Bolus vs 2-h Infusion of Alteplase in Acute Massive Pulmonary Embolism A Randomized Controlled Multicenter Trial Chest J 106 1994 712 717
17. A.A. Sasahara The urokinase pulmonary embolism trial: a national cooperative study 1973 American Heart Association
18. D. Tibbutt, J. Davies, J. Anderson, E. Fletcher, J. Hamill, and J. Holt et al. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism Br Med J 1 1974 343
19. B. Ly, H. Arnesen, H. Eie, and R. Hol A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism Acta Med Scand 203 1978 465 470
20. C.T. Dotter, A.J. Seaman, J. Rösch, and J.M. Porter Streptokinase and heparin in the treatment of pulmonary embolism: a randomized comparison Vasc Endovascular Surg 13 1979 42 52
21. C. Marini, G. Di Ricco, G. Rossi, M. Rindi, R. Palla, and C. Giuntini Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial Respiration 54 1988 162 173
22. C. Jerjes-Sanchez, A. Ramírez-Rivera, M. de Lourdes García, R. Arriaga-Nava, S. Valencia, and A. Rosado-Buzzo et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial J Thromb Thrombolysis 2 1995 227 229
23. G. Agnelli, A. Iorio, P. Parise, S. Goldhaber, and M. Levine Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism Blood Coagul Fibrinolysis 8 1997 216 222
24. S.Z. Goldhaber, G. Agnelli, and M.N. Levine Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis an international multicenter randomized trial Chest J 106 1994 718 724
25. M. Sharifi, C. Bay, L. Skrocki, F. Rahimi, and M. Mehdipour Moderate Pulmonary Embolism Treated With Thrombolysis (from the "MOPETT" Trial) Am J Cardiol 111 2012 273 277
26. M. Levine, J. Hirsh, J. Weitz, M. Cruickshank, J. Neemeh, and A.G. Turpie et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism Chest 98 1990 1473 1479
27. S. Geller Tissue plasminogen activator for the treatment of acute pulmonary embolism Chest 97 1990 528 533
28. S. Dalla-Volta, A. Palla, A. Santolicandro, C. Giuntini, V. Pengo, and O. Visioli et al. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2 J Am Coll Cardiol 20 1992 520 526
29. S. Goldhaber, P. Come, R. Lee, E. Braunwald, J. Parker, and W. Haire et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion Lancet 341 1993 507 511
30. S. Wan, D.J. Quinlan, G. Agnelli, and J.W. Eikelboom Thrombolysis compared with heparin for the initial treatment of pulmonary embolism a meta-analysis of the randomized controlled trials Circulation 110 2004 744 749
31. O. Sanchez, L. Trinquart, I. Colombet, P. Durieux, M.V. Huisman, and G. Chatellier et al. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review Eur Heart J 29 2008 1569 1577
32. C. Becattini, M.C. Vedovati, and G. Agnelli Prognostic value of troponins in acute pulmonary embolism a meta-analysis Circulation 116 2007 427 433
33. C. Dellas, M. Puls, M. Lankeit, K. Schäfer, M. Cuny, and M. Berner et al. Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism J Am Coll Cardiol 55 2010 2150 2157
34. G. Coutance, E. Cauderlier, J. Ehtisham, M. Hamon, and M. Hamon The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis Crit Care 15 2011 R103
35. C. Becattini, G. Agnelli, M.C. Vedovati, P. Pruszczyk, F. Casazza, and S. Grifoni et al. Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test Eur Heart J 32 2011 1657 1663